Center calls on states to be prepared for ‘adverse’ effects of vaccination | Indian News

NEW DELHI: The Union Ministry of Health said on Tuesday that India is doing relatively well in its fight against the Covid-19 pandemic, apart from talking about the way forward – vaccines.
Union Health Secretary Rajesh Bhushan said 29,000 cold chain points, 240 inbound refrigerators, 70 inbound freezers, 45,000 ice refrigerators, 41,000 deep freezers and 300 solar refrigerators will be used for that purpose. He added that all these equipments have already reached different states.
However, he also warned of the harms, saying such harms are mainly seen in children and pregnant women after vaccination.
Bhushan also alluded international cases to invent his cause, saying that India cannot deny the possibilities of adverse events when vaccination against Covid-19 begins. “In countries where immunization has already begun, particularly in the UK, adverse events have occurred on the first day,” he said.
Bhushan urged the states and UTs to prepare for such scenarios. He further said that the number of cases per million inhabitants in this country is still among the lowest in the world. While the global average remains 9,000, the number of cases in India is 7,178 per million inhabitants.
Meanwhile, VK Paul, a member (Health), NITI Aayog, acknowledged how Delhi’s Covid rise was controlled and congratulated the government for it. But he sternly warned against oversight, adding that the curve could also go awry.
“There are some states where we still have concerns,” he said, urging the government and citizens of Utarakhand, Nagaland and Himachal Pradesh to make “every effort” to control the current situation there.
“This week the Comptroller General of Medicines in India granted authorization for clinical trials of another vaccine candidate from India,” he said. A Genoese company, he said, with the help of the Center’s Biotechnology Department, has developed a vaccine.
The technology used in it is similar to Pfizer. However it can be stored in normal cold chain conditions, in a normal refrigerator, unlike Pfizer, Paul added. He claimed that to date six vaccines are undergoing clinical trials in India.